More information : CLICK HERE
PhRMA (USA) Signs New Policy Partnership Agreement with Government of Algeria To Develop Innovative Medicines Sector
PhRMA commits to helping Algeria achieve its “Vision 2020” strategy to strengthen the innovative biotechnology and pharmaceutical industry and improve human health San Diego (25 June 2014)
Representative of the Pharmaceutical Research and Manufacturers of America (PhRMA) have signed a Memorandum of Understanding (MOU) with the National Pharmaceutical Products Control Laboratory of Algeria, setting out a new framework for partnership on policies to encourage more innovation, employment and investment in this strategic sector in the Algerian economy, PhRMA announced here today.
In a recent interview at the Algerian Radio, the President of UNOP (National Union of Pharmaceutical Operators), Dr Abdelouahed Kerrar, stated that there are 70 operational pharmaceutical plants in Algeria and 117 new plant projects and investment on the table. This confirms the huge need of equipments and input necessary to follow these projects. The Algerian Pharma Industry is aiming at manufacturing locally 70 % of its needs. It is currently manufacturing 40 % of its needs and importing 60 % of them.